Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01799889
Title A Phase 2 of Entospletinib in Subjects With Relapsed or Refractory Hematologic Malignancies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gilead Sciences
Indications

mantle cell lymphoma

diffuse large B-cell lymphoma

B-cell lymphoma

chronic lymphocytic leukemia

Therapies

Entospletinib

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.